1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.22%
Revenue growth above 1.5x ENPH's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
64.11%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
165.49%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
49.95%
Operating income growth above 1.5x ENPH's 26.34%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
245.39%
Net income growth above 1.5x ENPH's 24.63%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
325.00%
EPS growth above 1.5x ENPH's 21.74%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
316.67%
Diluted EPS growth above 1.5x ENPH's 22.73%. David Dodd would see if there's a robust moat protecting these shareholder gains.
8.51%
Slight or no buybacks while ENPH is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
17.51%
Slight or no buyback while ENPH is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
105.32%
Positive OCF growth while ENPH is negative. John Neff would see this as a clear operational advantage vs. the competitor.
53.59%
Positive FCF growth while ENPH is negative. John Neff would see a strong competitive edge in net cash generation.
251.78%
10Y revenue/share CAGR above 1.5x ENPH's 20.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
251.78%
5Y revenue/share CAGR 1.25-1.5x ENPH's 174.77%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
283.50%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-97.12%
Negative 10Y OCF/share CAGR while ENPH stands at 176.50%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-97.12%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-56.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
143.82%
Below 50% of ENPH's 2178.31%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
143.82%
5Y net income/share CAGR at 75-90% of ENPH's 174.41%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
87.49%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
99.40%
3Y equity/share CAGR at 75-90% of ENPH's 112.35%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
96.93%
AR growth well above ENPH's 17.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
-23.39%
Inventory is declining while ENPH stands at 20.13%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
16.24%
Asset growth above 1.5x ENPH's 2.34%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
7.98%
75-90% of ENPH's 9.32%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
43.10%
Debt growth far above ENPH's 2.21%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-13.03%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
0.79%
We expand SG&A while ENPH cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.